KA/EN
Register
Medicines reference
Search
Search
Product

Hepastabilan

Favourites

· Nutrifarm Sp. z o.o. (Vebiot)

1 form: tablet. Not applicable (not a medicine).

Forms and dosesNot applicable (not a medicine)

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
60 tablets, Tablet · Cat up to 3 kg Cat up to 3 kg 1/2 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 0.5 tablet(s) once daily		 0.5 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Cat 3–5 kg Cat 3–5 kg 1 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 1 tablet(s) once daily		 1 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Cat 6–10 kg Cat 6–10 kg 1 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 1.5 tablet(s) once daily		 1.5 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Cat 11–15 kg Cat 11–15 kg 2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 2 tablet(s) once daily		 2 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Cat 16–20 kg Cat 16–20 kg 2 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 2.5 tablet(s) once daily		 2.5 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Cat over 20 kg Cat over 20 kg 3 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 3 tablet(s) once daily		 3 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Dog up to 3 kg Dog up to 3 kg 1/2 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 0.5 tablet(s) once daily		 0.5 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Dog 3–5 kg Dog 3–5 kg 1 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 1 tablet(s) once daily		 1 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Dog 6–10 kg Dog 6–10 kg 1 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 1.5 tablet(s) once daily		 1.5 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Dog 11–15 kg Dog 11–15 kg 2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 2 tablet(s) once daily		 2 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Dog 16–20 kg Dog 16–20 kg 2 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 2.5 tablet(s) once daily		 2.5 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
60 tablets, Tablet · Dog over 20 kg Dog over 20 kg 3 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 · 3 tablet(s) once daily		 3 tablet(s) once daily Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
Details: pack, label wording, sources, registration

Hepastabilan 60 tablets, Tablet

complementary feed, Vebiot
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Adjunctive nutritional support of physiological liver function after defining the underlying hepatobiliary disorder and cause-specific treatment plan
5.8/10
Weak evidence support
vetman assessment

Hepastabilan

60 tablets, complementary feed, Vebiot
Assessed clinical scopeDog · Adjunctive nutritional support of physiological liver function after defining the underlying hepatobiliary disorder and cause-specific treatment plan · By mouth
Care settingVeterinarian-directed home adjunct within a diagnosis-specific nutrition, treatment and monitoring plan.
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Not a medicine · Verified on 15 Oct 2026

A plausible, practical canine liver-support feed with a limited predecessor-product biomarker signal, but opaque current amounts and no exact-product clinical-outcome evidence keep it a weak adjunct rather than treatment.

Regulatory and scientific credibility5.0/10

The exact current pack, category, qualitative composition, tablet handling and six dose cells are traceable, but active amounts, complete label and quality controls are unpublished; the cited study used predecessor Hepaxan and current-formula equivalence is not proved.

Clinical efficacy5.5/10

A small Hepaxan study found improved surrogate liver markers in an uncontrolled 15-dog disease arm, while ACVIM and reviews support biological plausibility but emphasise limited clinical evidence; exact Hepastabilan outcomes and disease-specific benefit are unproved.

Safety and tolerability6.0/10

Related SAMe/silybin use is generally tolerated and the small predecessor study was reassuring, but exact current quantities, long-term target-animal cohorts and reproductive/juvenile data are absent; supplement stacking and polypharmacy remain material.

Clinical practicality7.5/10

Once-daily neutral tablets, quarter scoring and permission to split, crush or dissolve are workable at home; six cells, fractional-weight gaps and up to three tablets daily still require deliberate selection and adherence.

Full-course cost-effectiveness-

No verified current Georgian price and no evidence-defined course duration; price not assessed.

Important safety and use flags

  • Complementary feed, not a veterinary medicine. Category-correct “not applicable” medicine-authorisation status does not establish regulator-reviewed efficacy, quantitative composition or safety.
  • The current manufacturer page lists only yeast products, herbal complex, vitamin E and zinc. Per-tablet amounts repeated by distributors are not verified current manufacturer data and must not be used to calculate mg/kg exposure.
  • The manufacturer-cited 2021 study explicitly used Vebiot Hepaxan, not current Hepastabilan. No primary source proves identical formulation, manufacturing controls or bioavailability.
  • Use only the six printed once-daily weight cells. They leave fractional-weight gaps between 5/6, 10/11 and 15/16 kg; do not interpolate or turn the conflicting “1 tablet per 3–5 kg” prose into a continuous rule.
  • Adjunct only. Do not delay diagnosis or cause-specific treatment of hepatic failure, biliary obstruction, infection, toxin injury, copper-associated disease, lipidosis, cholangitis, pancreatitis or neoplasia.
  • Splitting, crushing or dissolving is manufacturer-permitted, but this does not make yeast-derived SAMe pharmacokinetically equivalent to the stable enteric-coated SAMe formulation used in feline research.
  • Review the complete diet and all liver/antioxidant supplements. Avoid unintended duplicate zinc, vitamin E, SAMe or silybin exposure; excess vitamin E can interfere with vitamin K/coagulation.
  • High-dose silybin may inhibit CYP enzymes and P-glycoprotein. Review polypharmacy, narrow-therapeutic-index medicines, antiplatelet/anticoagulant treatment and planned procedures.
  • Monitor appetite, vomiting, diarrhoea, weight and disease-appropriate liver biochemistry/imaging. A change in enzymes is a surrogate response, not proof that the underlying disease is controlled.
  • No regulator-reviewed, quantitative or independent exact-product evidence establishes long-term, pregnancy/lactation, breeding, juvenile or severe-hepatic-disease safety; use only after an individual benefit-risk review.
Assessment sources
  1. Hepastabilan current page2026
  2. Merck hepatic nutrition2026
  3. ACVIM canine hepatitis2019
  4. Canine liver nutraceutical review2013
  5. Vebiot Hepaxan dog study2021
  6. Canine silybin PK2007
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Adjunctive nutritional support of physiological liver function after defining the underlying hepatobiliary disorder and cause-specific treatment plan
5.3/10
Weak evidence support
vetman assessment

Hepastabilan

60 tablets, complementary feed, Vebiot
Assessed clinical scopeCat · Adjunctive nutritional support of physiological liver function after defining the underlying hepatobiliary disorder and cause-specific treatment plan · By mouth
Care settingVeterinarian-directed home adjunct within a diagnosis-specific nutrition, treatment and monitoring plan.
vetman score 5.3/10 Weak evidence support
Evidence confidence: Low Georgia: Not a medicine · Verified on 15 Oct 2026

A practical but weakly evidenced feline liver-support feed: current amounts and exact-product outcomes are unpublished, and the available cat SAMe evidence uses a materially different enteric formulation.

Regulatory and scientific credibility5.0/10

The exact current pack, category, qualitative composition, tablet handling and six dose cells are traceable, but active amounts, complete label and quality controls are unpublished; the cited study used predecessor Hepaxan and current-formula equivalence is not proved.

Clinical efficacy4.0/10

No exact-product feline disease-outcome trial was found. A different high-dose enteric-coated SAMe product altered redox measures in 15 healthy cats, which supports plausibility but not current Hepastabilan efficacy, dose equivalence or clinical benefit.

Safety and tolerability5.5/10

A different enteric SAMe product caused no overt toxicity in 15 healthy cats, but exact Hepastabilan exposure, repeated-use safety in liver disease and reproductive/juvenile data are absent; formulation transfer and duplicate zinc/vitamin E exposure matter.

Clinical practicality7.5/10

Once-daily neutral tablets, quarter scoring and permission to split, crush or dissolve are workable at home; six cells, fractional-weight gaps and up to three tablets daily still require deliberate selection and adherence.

Full-course cost-effectiveness-

No verified current Georgian price and no evidence-defined course duration; price not assessed.

Important safety and use flags

  • Complementary feed, not a veterinary medicine. Category-correct “not applicable” medicine-authorisation status does not establish regulator-reviewed efficacy, quantitative composition or safety.
  • The current manufacturer page lists only yeast products, herbal complex, vitamin E and zinc. Per-tablet amounts repeated by distributors are not verified current manufacturer data and must not be used to calculate mg/kg exposure.
  • The manufacturer-cited 2021 study explicitly used Vebiot Hepaxan, not current Hepastabilan. No primary source proves identical formulation, manufacturing controls or bioavailability.
  • Use only the six printed once-daily weight cells. They leave fractional-weight gaps between 5/6, 10/11 and 15/16 kg; do not interpolate or turn the conflicting “1 tablet per 3–5 kg” prose into a continuous rule.
  • Adjunct only. Do not delay diagnosis or cause-specific treatment of hepatic failure, biliary obstruction, infection, toxin injury, copper-associated disease, lipidosis, cholangitis, pancreatitis or neoplasia.
  • Splitting, crushing or dissolving is manufacturer-permitted, but this does not make yeast-derived SAMe pharmacokinetically equivalent to the stable enteric-coated SAMe formulation used in feline research.
  • Review the complete diet and all liver/antioxidant supplements. Avoid unintended duplicate zinc, vitamin E, SAMe or silybin exposure; excess vitamin E can interfere with vitamin K/coagulation.
  • High-dose silybin may inhibit CYP enzymes and P-glycoprotein. Review polypharmacy, narrow-therapeutic-index medicines, antiplatelet/anticoagulant treatment and planned procedures.
  • Monitor appetite, vomiting, diarrhoea, weight and disease-appropriate liver biochemistry/imaging. A change in enzymes is a surrogate response, not proof that the underlying disease is controlled.
  • No regulator-reviewed, quantitative or independent exact-product evidence establishes long-term, pregnancy/lactation, breeding, juvenile or severe-hepatic-disease safety; use only after an individual benefit-risk review.
Assessment sources
  1. Hepastabilan current page2026
  2. Merck hepatic nutrition2026
  3. Healthy-cat SAMe study2005
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Nutrifarm Sp. z o.o. (Vebiot) · Poland
Registration
Georgia Not a medicine
Not applicable (not a medicine)
Product label (Vebiot complementary feed (label))
Verified on: 15 Oct 2026
 EU Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 UK Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 US Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
Controlled in Georgia
Unknown
Information not fully verified Current once-daily dog/cat table: under 3 kg 0.5 tablet; 3–5 kg 1; 6–10 kg 1.5; 11–15 kg 2; 16–20 kg 2.5; over 20 kg 3. The printed cells leave fractional-weight gaps; do not interpolate or replace them with the conflicting prose “1 tablet per 3–5 kg.” Tablets may be split, crushed or dissolved. Current manufacturer material publishes only yeast products, herbal complex, vitamin E and zinc, not active amounts per tablet.
DoseSpeciesWeightRouteFrequencySource
1/2 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Cat up to 3 kg By mouth 0.5 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
1 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Cat 3–5 kg By mouth 1 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
1 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Cat 6–10 kg By mouth 1.5 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Cat 11–15 kg By mouth 2 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
2 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Cat 16–20 kg By mouth 2.5 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
3 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Cat over 20 kg By mouth 3 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
1/2 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Dog up to 3 kg By mouth 0.5 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
1 tablet
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Dog 3–5 kg By mouth 1 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
1 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Dog 6–10 kg By mouth 1.5 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Dog 11–15 kg By mouth 2 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
2 1/2 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Dog 16–20 kg By mouth 2.5 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026
3 tablets
Exact printed manufacturer weight cell. Tablets may be quartered, crushed or dissolved. The label leaves fractional-weight gaps between some cells; do not interpolate a continuous tablet/kg rule or infer an active-ingredient mg/kg dose from retailer composition figures.
 Dog over 20 kg By mouth 3 tablet(s) once daily
Hepastabilan current page
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hepastabilan 60 tablets - current exact product, qualitative composition and directions
Vebiot, 2026

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 16 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗